Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Mar;36(3):259-261.
doi: 10.1007/s40273-018-0613-x.

Price Transparency for Whom? In Search of Out-of-Pocket Cost Estimates to Facilitate Cost Communication in Cancer Care

Ya-Chen Tina Shih  1 , Shelley Fuld Nasso  2 , S Yousuf Zafar  3
Affiliations
Editorial

Price Transparency for Whom? In Search of Out-of-Pocket Cost Estimates to Facilitate Cost Communication in Cancer Care

Ya-Chen Tina Shih et al. Pharmacoeconomics. 2018 Mar.
No abstract available

PubMed Disclaimer

References

    1. Hillner BE, Smith TJ. Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab? Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2007 Feb 20;25(6):611–3. - PubMed
    1. Shih YC, Ganz PA, Aberle D, Abernethy A, Bekelman J, Brawley O, et al. Delivering high-quality and affordable care throughout the cancer care continuum. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2013 Nov 10;31(32):4151–7. - PMC - PubMed
    1. Shih YT, Xu Y, Liu L, Smieliauskas F. Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2017 Aug 01;35(22):2482–9. - PMC - PubMed
    1. Scalo JF, Rascati KL. Trends and issues in oncology costs. Expert review of pharmacoeconomics & outcomes research. 2014 Feb;14(1):35–44. - PubMed
    1. Zafar SY, Abernethy AP. Financial toxicity, Part I: a new name for a growing problem. Oncology. 2013 Feb;27(2):80–1. 149. - PMC - PubMed

Publication types

LinkOut - more resources